Skip to content
Home/Companies/Healthcare/Neopharmed Gentili
NG

Neopharmed Gentili

Healthcare·Italy·Exited 2025·Held 7yr

Neopharmed Gentili is a healthcare company, headquartered in Italy.

Entry
2018
Hold
7yr
Exit
2025
Est. EV
–

Who owns Neopharmed Gentili?

Neopharmed Gentili was owned by Ardian through Ardian Buyout Fund VII (2017 vintage) from 2018 to 2025, exited via Secondary.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

Ardian
Investor
Ardian
Ardian Buyout Fund VII · 2017 · Buyout

Key facts

HQItaly
SectorHealthcare
Exit Type
Secondary
Buyer
MOIC
–
Exit Year
2025

More from Ardian Buyout Fund VII

Other portfolio companies in the same fund.

Diot-Siaci
Active
FinancialsFrance
Kyobo Life Insurance
Exited 2025
FinancialsSouth Korea
to
Energia Group
Active
EnergyIreland· 2026
Ennov
Active
SoftwareFrance· 2026
Masco Group
Active
HealthcareItaly· 2024
Robot Coupe + Magimix
Exited 2025
ConsumerFrance· 2024
to

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
4ways
Active
ECI PartnersUK
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abcam (exited)
Active
EMV CapitalUK
Data refreshed weekly · Sourced from public filings